TB Europe Coalition releases a guide explaining the whole data collection process for four new indicators of the WHO Regional Office for Europe regarding the meaningful involvement of civil society in TB response.

A research team has detected various substances that have a dual effect against tuberculosis: They make the bacteria causing the disease less pathogenic for human immune cells and boost the activity of conventional antibiotics.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

RESIST-TB released its January 2024 newsletter with the latest updates and research publications on drug-resistant TB.

A survey of national tuberculosis (TB) program staff members projects consistent global growth in the use of shorter, all-oral drug regimens for drug-resistant TB (DR-TB), but national efforts to ensure the new treatments are accessible to eligible patients are needed, researchers reported late last week in PLOS One.

Sign up for a Call to Action for accelerating the implementation of shorter and more effective treatment for all people with drug-resistant TB.

The Global TB CAB and TAG commend the investigators for sharing results early and openly with a diverse group of key stakeholders, and urge the scientific community and funders to continue efforts to find different options to prevent TB.

Diabetes mellitus may lead to adverse outcomes in multidrug-resistant tuberculosis (MDR-TB) or DR-TB, according to systematic review and meta-analysis findings published in BMC Infectious Diseases.

Vaccine well tolerated and demonstrated immunogenicity but did not provide protection against TB recurrence; Participants being informed; Further analysis continues.

Tuberculosis (TB) has regained its place as the leading infectious killer worldwide. Annually, 1.6 million people die of this disease which is the equivalent to three TB deaths per minute. While the TB pandemic is driven by five key risk factors – undernutrition, HIV, alcohol use, tobacco use and diabetes – the extent of mismatch between their impact on TB and available research funding is unclear.